Fears big data could affect insurance coverage and be used to track the performance of clinicians are holding back adoption. But big data means better data, according to speakers at a Science|Business conference

To fight growing antimicrobial resistance, the use of existing antimicrobial drugs should be restricted, and there should be incentives for new ones should be developed

Factoring real world evidence and patients’ opinions into the operation of healthcare systems can reduce inequality within and between countries, whilst increasing sustainability. We need to start by measuring outcomes

The Science|Business interview: Top EU health official outlines a push for better performance, crisis management – linked to Juncker economic agenda

A new online platform ShareIn is connecting biotech companies with investors. This is forcing traditional funders to up their game and cut back on layers of intermediary costs for start-ups, says Jude Cook, co-founder of ShareIn

Digital technologies can help older adults maintain independence and assist with their care. But resistance to change and a shortage of objective data to help communicate its value, is making it hard to commercialise products and build markets, says Martijn Vastenburg

Smartphones can help you understand and look after your health says Bruce Hellman, chief executive of health app start-up uMotif

The European Medicines Agency should play a greater role in monitoring shortfalls, a new study suggests

A new EU data protection law risks killing some types of medical research, researchers at the Karolinska Institutet say. Their prescription: A law that regulates Big Data, but allows for research

Drive-AB has €9.4M to develop new business models to promote industry investment in antibiotics and prevent their inappropriate use